4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine

C19H25N3O2 — CID 133368215

IUPAC4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine
SMILESCOc1cccc2c(N3CCC(N4CCOCC4)C3)cc(C)nc12
InChIInChI=1S/C19H25N3O2/c1-14-12-17(16-4-3-5-18(23-2)19(16)20-14)22-7-6-15(13-22)21-8-10-24-11-9-21/h3-5,12,15H,6-11,13H2,1-2H3
InChIKeyZREYOQQAMLAZGK-UHFFFAOYSA-N
MW327.43 g/mol
LogP2.46
Rot. Bonds3

About 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine

4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine (PubChem CID 133368215) has the molecular formula C19H25N3O2 and a molecular weight of 327.43 g/mol. Its IUPAC name is 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine.

Molecular Properties

Compound Name4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine
PubChem CID133368215
Molecular FormulaC19H25N3O2
Molecular Weight327.43 g/mol
Exact Mass327.19
IUPAC Name4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine
SMILESCOc1cccc2c(N3CCC(N4CCOCC4)C3)cc(C)nc12
InChIInChI=1S/C19H25N3O2/c1-14-12-17(16-4-3-5-18(23-2)19(16)20-14)22-7-6-15(13-22)21-8-10-24-11-9-21/h3-5,12,15H,6-11,13H2,1-2H3
InChIKeyZREYOQQAMLAZGK-UHFFFAOYSA-N
XLogP2.46
TPSA37.83 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500327.43
LogP ≤ 52.46
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[3-(ethoxymethyl)pyrrolidin-1-yl]-8-methoxy-2-methylquinoline
CID 133368592
4-(8-methoxy-2-methylquinolin-4-yl)-2-(5-methyl-1H-1,2,4-triazol-3-yl)morpholine
CID 133368789
8-methoxy-2-methyl-4-[4-(pyrazol-1-ylmethyl)piperidin-1-yl]quinoline
CID 133388481
4-(2,8-dimethylquinolin-4-yl)morpholine
CID 71424846
4-[3-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-3-yl)piperidin-1-yl]-8-methoxy-2-methylquinoline
CID 133388588
1-(4-ethylpiperazin-1-yl)-2-[1-(8-methoxy-2-methylquinolin-4-yl)piperidin-4-yl]ethanone
CID 133388704
5-[4-(8-methoxy-2-methylquinolin-4-yl)-1,4-diazepan-1-yl]-3-methyl-1,2,4-thiadiazole
CID 133368334
1-(8-methoxy-2-methylquinolin-4-yl)-N-(pyridin-3-ylmethyl)piperidine-4-carboxamide
CID 133453800
trans-(1S,2S)-1-N,2-N-bis(8-methoxy-4-pyrrolidin-1-ylquinolin-2-yl)cyclohexane-1,2-diamine
CID 118548103
2-methyl-8-nitro-4-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline
CID 133436763
4-[1-[2-methyl-7-(trifluoromethyl)quinolin-4-yl]piperidin-4-yl]morpholine
CID 134713018
4-[1-(3-methylquinoxalin-2-yl)pyrrolidin-3-yl]morpholine
CID 172900398

Frequently Asked Questions

What is the IUPAC name of 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine?
The IUPAC name of 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine (CID 133368215) is 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine.
What is the SMILES notation for 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine?
The canonical SMILES for 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine is COc1cccc2c(N3CCC(N4CCOCC4)C3)cc(C)nc12.
What is the InChIKey of 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine?
The InChIKey is ZREYOQQAMLAZGK-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H25N3O2/c1-14-12-17(16-4-3-5-18(23-2)19(16)20-14)22-7-6-15(13-22)21-8-10-24-11-9-21/h3-5,12,15H,6-11,13H2,1-2H3.
What are the key properties of 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine?
4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine has a molecular weight of 327.43 g/mol, XLogP of 2.46, 3 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[1-(8-methoxy-2-methylquinolin-4-yl)pyrrolidin-3-yl]morpholine is sourced from PubChem (CID 133368215), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).